that time vaccination is still ongoing

Posted by RiverOfSilver > May 13, 2021 8:33 PM | Report Abuse

maybe it takes some time for the surge to flatten, post-vaccination

it was also still surging in israel, immediately post-vaccination

no point using israel numbers before vaccination

see the recent case counts...its rising rapidly...hitting 300 per day... israel is below 50...

former 100k population....latter is 10milliom

Malaysia have the money to buy leh....they can afford to pay higher.. the more they pay, the faster the vaccine will arrive..manufacturer will prioritize..

but chose to compromise....and this is ultimate stup**ty

let us not waste malaysian time leh...you are wasting another year

what Israel has Malaysia cannot afford? you can buy 10m but you cannot another 20M?

stop wasting people's time and make a mess

let us not waste malaysian time leh...you are wasting another year

what Israel has Malaysia cannot afford? you can buy 10m but you cannot another 20M?

stop wasting people's time and make a mess

let us not waste time leh...you are wasting another year

what Israel has Malaysia cannot afford? you can buy 10m but you cannot another 20M?

stop wasting people's time and make a mess

or even astrazeneca or any other having lesser efficacy...avoid it...

every drop of efficacy matters a lot on this battle

now that the data is available, it would be pure stup**ty to go for china vaccines

now that the data is available, it would be pure stup**ty to go for china vaccines

raider & uncle Koon, i suggest you all go for China's vaccine (due to your blood patriotism & ego)...and give chance for others in Malaysia for Pfizer

raider & uncle Koon, i suggest you all go for China's vaccine (due to your blood patriotism & ego)...and give chance for others in Malaysia for Pfizer

Post removed.Why?

Post removed.Why?

Post removed.Why?

dont let Malaysia suffer another 2 years...or even longer

get all vaccinated with Pfizer
............................

else it will be a breeding ground for new variants which are more resistant to the vaccine

the best way to make it stronger is to challenge but not eliminating it

dont let Malaysia suffer another 2 years...or even longer

get all vaccinated with Pfizer

else it will be a breeding ground for new variants which are more resistant to the vaccine

the best way to make it stronger is to challenge but not eliminating it

dont let Malaysia suffer another 2 years...or even longer

get all vaccinated with Pfizer
.............................

else it will be a breeding ground for new variants which are more resistant to the vaccine

the best way to make it stronger is to challenge but not eliminating it

infact it is our ego which can be very bias

Numbers dont lie...

Seychelles

https://www.worldometers.info/coronavirus/country/seychelles/

compare Israel with Pfizer

https://www.worldometers.info/coronavirus/country/israel/

raider i am not comparing china with west / U.S...i am telling what Malaysia should be doing...

you can keep your ego boosting to yourself

raider i am not comparing china with west / U.S...i am telling what Malaysia should be doing...

you can keep your ego boosting to yourself

“You really need to use high-efficacy vaccines to get that economic benefit because otherwise they’re going to be living with the disease long-term,” said Raina MacIntyre,

.........

you dont want to end up as breeding ground for new variants...

do it right when you have choice - Malaysia should go all out for Pfizer , else they are wasting resources and letting them self be experimented

https://www.nytimes.com/2021/05/12/business/economy/covid-seychelles-sinopharm.html

Seychelles

China expected its Sinopharm vaccines to be the lynchpin of the country’s vaccine diplomacy programme – an easily transported dose that would protect not just Chinese citizens but also much of the developing world. In a bid to win goodwill, China has donated 13.3 million Sinopharm doses to other countries, according to Bridge Beijing, a consultancy that tracks China’s impact on global health.

Instead, the company, which has made two varieties of coronavirus vaccines, is facing mounting questions about the inoculations. First, there was the lack of transparency with its late-stage trial data. Now, Seychelles, the world’s most vaccinated nation, has had a surge in cases despite much of its population being inoculated with Sinopharm.

For the 56 countries counting on the Sinopharm shot to help them halt the pandemic, the news is a setback. For months, public health experts had focused on trying to close the access gap between rich and poorer nations. Now, scientists are warning that developing nations that choose to use the Chinese vaccines, with their relatively weaker efficacy rates, could end up lagging behind countries that choose vaccines made by Pfizer-BioNTech and Moderna. That gap could allow the pandemic to continue in countries that have fewer resources to fight it.

Economic benefit
...............

“You really need to use high-efficacy vaccines to get that economic benefit because otherwise they’re going to be living with the disease long-term,” said Raina MacIntyre, who heads the biosecurity programme at the Kirby Institute of the University of New South Wales in Sydney. “The choice of vaccine matters.”

Seychelles

China expected its Sinopharm vaccines to be the lynchpin of the country’s vaccine diplomacy programme – an easily transported dose that would protect not just Chinese citizens but also much of the developing world. In a bid to win goodwill, China has donated 13.3 million Sinopharm doses to other countries, according to Bridge Beijing, a consultancy that tracks China’s impact on global health.

Instead, the company, which has made two varieties of coronavirus vaccines, is facing mounting questions about the inoculations. First, there was the lack of transparency with its late-stage trial data. Now, Seychelles, the world’s most vaccinated nation, has had a surge in cases despite much of its population being inoculated with Sinopharm.

For the 56 countries counting on the Sinopharm shot to help them halt the pandemic, the news is a setback. For months, public health experts had focused on trying to close the access gap between rich and poorer nations. Now, scientists are warning that developing nations that choose to use the Chinese vaccines, with their relatively weaker efficacy rates, could end up lagging behind countries that choose vaccines made by Pfizer-BioNTech and Moderna. That gap could allow the pandemic to continue in countries that have fewer resources to fight it.

Economic benefit
...............

“You really need to use high-efficacy vaccines to get that economic benefit because otherwise they’re going to be living with the disease long-term,” said Raina MacIntyre, who heads the biosecurity programme at the Kirby Institute of the University of New South Wales in Sydney. “The choice of vaccine matters.”

https://klse.i3investor.com/servlets/forum/600522246.jsp

“You really need to use high-efficacy vaccines to get that economic benefit because otherwise they’re going to be living with the disease long-term,” said Raina MacIntyre

Seychelles

https://www.worldometers.info/coronavirus/country/seychelles/

compare Israel with Pfizer

https://www.worldometers.info/coronavirus/country/israel/

“The choice of vaccine matters.”

China expected its Sinopharm vaccines to be the lynchpin of the country’s vaccine diplomacy programme – an easily transported dose that would protect not just Chinese citizens but also much of the developing world. In a bid to win goodwill, China has donated 13.3 million Sinopharm doses to other countries, according to Bridge Beijing, a consultancy that tracks China’s impact on global health.

Instead, the company, which has made two varieties of coronavirus vaccines, is facing mounting questions about the inoculations. First, there was the lack of transparency with its late-stage trial data. Now, Seychelles, the world’s most vaccinated nation, has had a surge in cases despite much of its population being inoculated with Sinopharm.

For the 56 countries counting on the Sinopharm shot to help them halt the pandemic, the news is a setback. For months, public health experts had focused on trying to close the access gap between rich and poorer nations. Now, scientists are warning that developing nations that choose to use the Chinese vaccines, with their relatively weaker efficacy rates, could end up lagging behind countries that choose vaccines made by Pfizer-BioNTech and Moderna. That gap could allow the pandemic to continue in countries that have fewer resources to fight it.

Economic benefit
...............

“You really need to use high-efficacy vaccines to get that economic benefit because otherwise they’re going to be living with the disease long-term,” said Raina MacIntyre, who heads the biosecurity programme at the Kirby Institute of the University of New South Wales in Sydney. “The choice of vaccine matters.”

yes Pfizer i have a lot of confidence from Israel results...we can clearly see cases and death has gone down tremendously

bear in mind they have no restriction there now...and crowded as hell with all the religous gatherings

Vietnam with 98m people can do it....

if a country of more than a billion population can do it...its a shame for 30 million country with such a developed condition, lesser density..admit they cant

truly a shame

u can choose to be like China and prosper at the weakness of others..

like a drunkman addicted to booze

Posted by stockraider > May 13, 2021 2:08 PM | Report Abuse

U cannot end covid...we must live with it mah!

sorry little boy and fat man

u need a nuclear bomb like big brother in hiroshima to end it

we clearly would like to live with the virus with the compromised life like scavengers all for the sake of short term economic damage we want to prevent...

further the vaccination with the low efficacy vaccines used and current speed of implementation... you will see such cases even till next raya

and by then, a new variant would have emerge that escapes the vaccine

we have failed when we had allowed the ICU reach 100% level

so the SOP implemented is definitely insufficient

i said mandatory vaccination of all 100% and followed by strict SOP to even prevent any potential mutation from remnant cases, till it goes to very low level < 100

once it hits that level, with 100% vaccination its very difficult to climb back after removal of restrictions completely

read carefully

yes raider, what i am afraid is that some countries which are fully vaccinated..are still having rising cases like seychelles as the covid cases became too rampant inducing mutations which can still survive

we need multiple weapons in one go
economic damage can be significant but its still lesser than the cumulative effects of such slow control...

vaccination, unless it is done with Pfizer with 95% efficacy, even with full vaccination...this thing is not going to end

check syechelles

Posted by stockraider > May 13, 2021 1:19 PM | Report Abuse

Too late to use China method of totally lockdown loh...too much economic damage mah!

The key is still mass vaccination until it reaches full herd immunity level mah!

why cant we all learn from china, vietnam?

Step 1 - practise strict SOP as above countries done (it only takes a few months of intense discipline)

Step 2 - have absolute strict controls at the borders, long quarantine requirement with repeated covid test before entry

Step 3- make the vaccination mandatory

Step 4 - use the best vaccine with highest efficacy (as it has significant effect on herd immunity, do not compromise with low efficacy)

...

we seem to want to reduce...but not eliminate...we seem to do chemotherapy half way and allow the cancer to keep recurring...

we are not in love & hate relationship with this virus..

its either your eliminate and live a normal life...or you dont live...its not worth to live like this for the sake of economy

do not treat yourself like modern slaves...like those chickens in chicken coops...only exist for economic reason

we have only one life...quality is more important than quantity

recent acquisition wont have effect on P&L, but the below took place in Q1 and the senai deals might


https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3125403

means we can at the least expect about 500m in Q1 from Engineering

for Port & logistics its 'confirmed' revenue is more than 900m


Posted by pingdan > May 10, 2021 10:31 AM | Report Abuse

984mil JV revenue to be recognised by 1 May 2021...

Baltic index gains on higher rates across vessels

in Dry Bulk Market,International Shipping News 11/05/2021

https://www.hellenicshippingnews.com/baltic-index-gains-on-higher-rates-across-vessels/

The Baltic exchange’s main sea freight index rose on Monday, buoyed by an uptick in rates for all vessel segments.

The Baltic dry index .BADI , which tracks rates for capesize, panamax and supramax vessels ferrying dry bulk commodities, rose by 57 points, or nearly 1.8%, to 3,240.

MMC one of few stocks which wont be affected by MCO or local covid cases as its port business is mainly transhipment

This is defensive stock

after so much of articles...elephant managed to move up 1 cent! LOL...

better than nothing

March’s Suez Canal blockage “will be nothing compared to the [supply chain] disruption coming from being unable to change crews”, said Mark O’Neil, president of InterManager, which represents the crew management industry.

Last summer, about 400,000 seafarers were stranded at sea beyond their contract length because of the pandemic. While that number has fallen, fears are growing due to the global surge in coronavirus cases since March.

“If the travel restrictions continue as they are, we could once again be in a similar situation to the global crew change crisis that we saw in 2020,” said Niels Bruus, head of marine human resources at Maersk, the world’s largest container shipping company.

..........

China will be forced to replace shortage from India, all ports enroute from China to Europe will be super congested....

India’s Covid surge rocks global shipping industry

https://www.ft.com/content/cf40d764-6ab6-4638-bea6-594cc3cd5d53

Ports around world turn away vessels as crew from south Asian country contract disease

Ports including Singapore, pictured, have barred ships from changing crew members who have recently travelled from India

India’s huge wave of Covid-19 infections has hit the international shipping industry, which relies on the country for seafarers, as crews come down with the disease and ports deny entry to vessels.

Ports including Singapore and Fujairah in the United Arab Emirates have barred ships from changing crew members who have recently travelled from India, notices from maritime authorities show. Zhoushan in China has banned the entry of ships or crew that have visited India or Bangladesh in the past three months, according to Wilhelmsen Ship Management, a crew provider.

Industry executives also said that crews coming from India were testing positive for Covid-19 on ships, despite quarantining and testing negative before boarding.

“Earlier we had ships that were infected with one or two people,” said Rajesh Unni, chief executive of Singapore-based Synergy Marine Group, which provides ship crew. “Today, we have a scenario where whole ships are being infected very quickly . . . which means the ships themselves are immobilised.”

India on Thursday reported more than 410,000 Covid-19 infections and almost 4,000 deaths over the previous day. A surge in cases has broken global records and overwhelmed health systems.

India’s wake up call to the world

South Africa’s port authority said a vessel that arrived in Durban from India this week was quarantined after 14 Filipino crew tested positive for Covid-19. The ship’s chief engineer died of a heart attack.

Along with the Philippines and China, India is one of the world’s largest sources of sea crew. About 240,000 of an estimated 1.6m seafarers globally are from the country, according to International Chamber of Shipping, an industry body

Singapore, a big shipping hub, has widened its ban to cover crew from countries including Pakistan and Bangladesh.

Executives warned the restrictions could send shockwaves through the stretched shipping industry, which transports 80 per cent of global trade, according to UN data.


March’s Suez Canal blockage “will be nothing compared to the [supply chain] disruption coming from being unable to change crews”, said Mark O’Neil, president of InterManager, which represents the crew management industry.

Last summer, about 400,000 seafarers were stranded at sea beyond their contract length because of the pandemic. While that number has fallen, fears are growing due to the global surge in coronavirus cases since March.

“If the travel restrictions continue as they are, we could once again be in a similar situation to the global crew change crisis that we saw in 2020,” said Niels Bruus, head of marine human resources at Maersk, the world’s largest container shipping company.

“The situation has gone from bad to worse when it comes to crew changes. And that’s an understatement,” said Carl Schou, chief executive of Wilhelmsen, which sources 15 per cent of its approximately 10,000 workers from India. 

The Norwegian-owned company stopped crew changes in India from April 24 until at least the end of May. Schou added that Covid-19 test results for Indian sailors were not coming through in time for their scheduled departures since “the whole health system has basically collapsed in India”.

Bernhard Schulte Shipmanagement, a German crew management group, said it was temporarily drafting in seafarers from other nations to replace Indians disembarking or scheduled to board ships.

Shipping executives said that seafarers needed to be prioritised in the global vaccination rollout as countries introduce inoculation requirements to enter. But they have been frustrated by the slow pace of efforts to secure jabs through the International Maritime Organization, the UN body responsible for shipping.

“We’re simply tearing our hair out with the bureaucracy and political ping-pong going over this issue of vaccinations,” said O’Neil.